NOX66 as Monotherapy, and in Combination With Carboplatin, in Patients With Refractory Solid Tumors: Phase Ia/b Study

NOX66 as Monotherapy, and in Combination With Carboplatin, in Patients With Refractory Solid Tumors: Phase Ia/b Study

ABSTRACT: Background: Although oral and intravenous forms of idronoxil have been well tolerated, the safety of NOX66, with idronoxil formulated as a rectal suppository, is not known. This Phase Ia/b clinical study (protocol No. NOX66-001A), known as Chemotherapy Enhancement Program-1, is the first t...

Full description

Saved in:
Bibliographic Details
Main Authors: Koba Kiknavelidze, PhD (Author), Mikheil Shavdia, PhD (Author), Nana Chikhladze, PhD (Author), Lia Abshilava, PhD (Author), Marinella Messina, PhD (Author), Gisela Mautner, MD, PhD (Author), Graham Kelly, PhD (Author)
Format: Book
Published: Elsevier, 2021-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items